Kai Yan
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Membranolytic peptide programs immunogenic cell death for cancer therapy.
Journal: Nature
Published: March 19, 2024
Citrullination modulation stabilizes HIF-1α to promote tumour progression.
Journal: Nature communications
Published: November 21, 2023
Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8+ T cells in hepatocellular carcinoma.
Journal: Journal of hepatology
Published: September 04, 2023
Spatial transcriptomics reveals prognosis-associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment.
Journal: Clinical and translational medicine
Published: August 02, 2023
Itaconate promotes hepatocellular carcinoma progression by epigenetic induction of CD8+ T-cell exhaustion.
Journal: Nature communications
Published: April 27, 2023
Immune profiling identifies CD8+ T-cell subset signatures as prognostic markers for recurrence in papillary thyroid cancer.
Journal: Frontiers in immunology
Published: March 12, 2022
Multi-Omics Profiling Identifies Pathways Associated With CD8+ T-Cell Activation in Severe Aplastic Anemia.
Journal: Frontiers in genetics
Published: October 07, 2021
Association between programmed cell death ligand 1 expression and thyroid cancer: A meta-analysis.
Journal: Medicine
Published: August 17, 2020
Multi-omics analysis identifies FoxO1 as a regulator of macrophage function through metabolic reprogramming.
Journal: Cell death & disease
Published: January 10, 2020
Last Updated: 09/26/2026